ArticleMolecular therapy. Methods & clinical development2023

In-depth comparison of Anc80L65 and AAV9 retinal targeting and characterization of cross-reactivity to multiple AAV serotypes in humans.

Maura K Schwartz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.